The lab experience you’re looking for, within a more complete clinical platform. Order, manage, and turn results into personalized plans in one seamless flow. Learn more
Anti-Sm/RNP, or Sm/RNP Antibody, is a special kind of protein created by your body's defense system. It's interesting because it interacts with specific parts found within your own cells, particularly in the nucleus, which is the cell's command center. The "Sm" and "RNP" in its name stand for Smith and ribonucleoprotein, two types of proteins that are part of the cell's nucleus. This antibody is often studied in relation to autoimmune diseases, where the body's defense system mistakenly attacks its own tissues. It's a fascinating aspect of the immune system's complexity, showcasing the delicate balance our bodies work to maintain.
If Your Levels Are High
Elevated levels of Anti-Sm/RNP might mean that your body's immune system is working harder than usual, possibly due to factors like certain medications, exposure to environmental triggers, or an imbalance in your immune system. It could also be a sign that your body is dealing with some internal stress, like inflammation or an infection. High levels of these antibodies are often linked to autoimmune diseases, where your immune system mistakenly attacks your own cells. This can interfere with how your cells, especially those in the nucleus (the cell's control center), function properly. Some specific diagnoses associated with high Anti-Sm/RNP levels include lupus and mixed connective tissue disease.
Symptoms of High Levels
Symptoms of high levels of Anti-Sm/RNP could include fatigue, joint pain, muscle weakness, and skin rashes. Some individuals may also experience sensitivity to sunlight, unexplained fever, or problems with organs such as the kidneys or lungs.
If Your Levels are Low
Low levels of Anti-Sm/RNP antibodies might mean that your body isn't producing these proteins in the usual amounts. This can happen for various reasons, such as your immune system's unique way of responding, certain medications like immunosuppressants, or your overall health. It's worth noting that these antibodies are often linked to autoimmune diseases, so having lower levels could suggest a lower chance of having these conditions. However, it's also possible that your immune system is just not reacting in the typical way, which is not unusual since everyone's immune response can be different.
Symptoms of Low Levels
Symptoms of low levels of Anti-Sm/RNP are typically not noticeable, as this condition primarily reflects an internal immune response rather than causing outward signs or discomfort.
This test measures antinuclear antibodies and other related markers to help diagnose autoimmune disease. Antinuclear antibodies are present in systemic lupus erythematosus, Sjogren’s Syndrome, scleroderma, mixed connective tissue disease, drug-induced lupus, and rheumatoid arthritis.
ANA Screen + 11 ANA Components by Access Med Labs
Serum
The ANA Screen detects the presence of clinically relevant circulating autoantibodies in serum. Antinuclear antibodies are present in systemic lupus erythematosus, Sjogren’s Syndrome, scleroderma, mixed connective tissue disease, drug induced lupus, and rheumatoid arthritis.
ANA 11 Components (no ANA Screen) by Access Med Labs
Serum
This test measures 11 antinuclear antibodies to help diagnose autoimmune disease. Antinuclear antibodies are present in systemic lupus erythematosus, Sjogren’s Syndrome, scleroderma, mixed connective tissue disease, drug-induced lupus, and rheumatoid arthritis.
Sm/RNP Abs by Access Med Labs
Serum
This is a single-marker test measuring Sm/RNP autoantibodies. This assay is used to help diagnose mixed connective tissue disease.
ANAlyzeR™ ANA, IFA with Reflex Titer/Pattern, Systemic Autoimmune Panel 1 by Quest Diagnostics
Serum
ANAlyzeR™ ANA, IFA with Reflex Titer/Pattern, Systemic Autoimmune Panel 1 - This panel can be helpful in the diagnosis of systemic rheumatic disorders and other autoimmune diseases. Although the test for antinuclear antibodies (ANA) is strongly associated with systemic lupus erythematosus (SLE), the laboratory evaluation for individuals with clinical suspicion of a variety of autoimmune diseases often begins with an ANA screen. This panel simultaneously tests for ANA (using immunofluorescence) as well as the important specific autoantibodies associated with a positive ANA. It also includes testing for complement proteins, rheumatoid arthritis, Sjogren's syndrome, systemic sclerosis, polymyositis, anti-phospholipid antibody syndrome, and autoimmune thyroid disease.